Changes Associated With the Entry of a Biosimilar in the Insulin Glargine Market.

2021 
This study explores the shifts in total US sales and net prices for all 3 insulin glargine products from quarter 1 of 2010 through quarter 2 of 2020.
    • Correction
    • Source
    • Cite
    • Save
    • Machine Reading By IdeaReader
    3
    References
    0
    Citations
    NaN
    KQI
    []